Author: Fiona Craig
-
Veradermics Shares Jump 17% on Promising Hair Loss Trial Results
Veradermics Incorporated (NYSE:MANE) saw its stock rise 17% on Monday after announcing positive topline data from a Phase 2/3 clinical study of its oral hair loss treatment, VDPHL01. The trial, known as Study ’302’, included 519 participants and successfully met all primary and key secondary endpoints with statistical significance. VDPHL01, an extended-release formulation of minoxidil,…
-
HBT Financial Tops Forecasts as CNB Acquisition Lifts Performance
HBT Financial Inc. (NASDAQ:HBT) reported first-quarter results on Monday that exceeded expectations, supported by the recent acquisition of CNB Bank Shares, with the stock rising 2.10% in pre-market trading. Adjusted earnings per share came in at $0.68, ahead of analyst forecasts of $0.62, while revenue reached $67.33 million, surpassing estimates of $66.75 million. The company…
-
Oruka Therapeutics Shares Jump on Strong Psoriasis Trial Results
Oruka Therapeutics Inc. (NASDAQ:ORKA) saw its shares surge 45% after releasing encouraging Week 16 data from its ongoing EVERLAST-A Phase 2a study in patients with moderate-to-severe plaque psoriasis. The trial met its primary objective, with 63.5% of patients treated with ORKA-001 achieving PASI 100 at Week 16, indicating complete skin clearance. An identical proportion also…
-
Alliance Resource Partners Shares Climb on Revenue Beat Despite Earnings Miss
Alliance Resource Partners L.P. (NASDAQ:ARLP) posted first-quarter results on Monday that fell short of earnings expectations but came in slightly ahead on revenue, prompting a positive reaction in early trading. The stock rose 3.61% in pre-market activity following the release. The company reported adjusted earnings per share of $0.07, missing analyst forecasts of $0.34. However,…
-
AstraZeneca Gains FDA Nod for SAPHNELO At-Home Injection in Lupus Care
AstraZeneca plc (NASDAQ:AZN) has been granted approval by the U.S. Food and Drug Administration for a new self-injection format of SAPHNELO (anifrolumab-fnia), enabling adult patients with systemic lupus erythematosus (SLE) to administer the treatment once weekly at home alongside standard therapy. The approval is based on results from the Phase III TULIP-SC trial, which found…
-
Futures Suggest Flat Start for Wall Street: Dow Jones, S&P, Nasdaq
U.S. stock futures indicate a largely unchanged open on Monday, pointing to a pause in momentum after the strong gains recorded in the previous session. Investors appear cautious, with limited conviction as uncertainty persists in the Middle East following the breakdown of U.S.-Iran peace discussions over the weekend. As negotiations between Washington and Tehran enter…
-
Five Key Market Themes to Watch in the Week Ahead
It’s shaping up to be a packed week for financial markets. With U.S.-Iran negotiations stalled and the Strait of Hormuz largely closed, investors are navigating a mix of geopolitical risks, a heavy earnings calendar, major central bank decisions and key economic data releases. 1. U.S.-Iran tensions remain in focus Market participants are bracing for continued…
-
Tower Semiconductor and Axiro Launch U.S.-Made Defense Radar Chips
Tower Semiconductor Ltd. (NASDAQ:TSEM) has partnered with Axiro Semiconductor to introduce new radar beamforming integrated circuits produced at Tower’s U.S. manufacturing sites using Silicon Germanium (SiGe) technology. The chips are tailored for defense radar systems and satellite communications, with Ku- and X-band beamforming ICs now moving into volume production, according to a joint announcement. Axiro…
-
ON Semiconductor Deepens Partnership With NIO on 900V EV Technology
ON Semiconductor Corporation (NASDAQ:ON) has broadened its strategic partnership with NIO Inc. (NYSE:NIO) to support the rollout of next-generation 900V electric vehicle platforms, according to a company announcement. The collaboration will incorporate onsemi’s EliteSiC enhanced M3e technology as NIO transitions from 400V to 900V system architectures. The solution is designed to enhance switching efficiency through…
-
Qualcomm Surges Premarket on Report of OpenAI Smartphone Chip Collaboration
Shares of Qualcomm Incorporated (NASDAQ:QCOM) jumped sharply in premarket trading on Monday, building on strong gains from the previous session, as new analyst commentary highlighted a potential long-term growth driver linked to OpenAI. The stock climbed about 9.2% ahead of the open after TF International Securities analyst Ming-Chi Kuo reported that industry checks indicate OpenAI…